Funding Rounds
Nouscom

Nouscom Series B (2017, $45M)

Nouscom

Viral vector-based cancer vaccines developer.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $45.80M

Raised Date: 2017-06-01

Investors